Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 211 AL 225

Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer's disease: a comprehensive review of the characteristics and therapeutic strategies

Nam Y, Shin SJ, Kumar V, Won J, Kim S, Moon M.

Transl Neurodegener. 2025 Mar 26;14(1):15. doi: 10.1186/s40035-025-00479-4.

Cholesterol´s role in membrane organization and nicotinic acetylcholine receptor function: Implications for aging and Alzheimer's disease

Peñalva DA, Munafó JP, Antollini SS.

Chem Phys Lipids. 2025 Jul;269:105484. doi: 10.1016/j.chemphyslip.2025.105484. Epub 2025 Mar 25.

Targeting amyloidogenic proteins through cyclic peptides - A medicinal chemistry perspective

Zargaham MK, Ibrahim A, Ahmed M, Babar MM, Rajadas J.

Bioorg Med Chem. 2025 Jun 1;123:118165. doi: 10.1016/j.bmc.2025.118165. Epub 2025 Mar 19.

Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition

Almohmadi NH, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Fakhry MM, Alexiou A, Papadakis M, Batiha GE.

Chem Biodivers. 2025 Aug;22(8):e202403401. doi: 10.1002/cbdv.202403401. Epub 2025 Jun 3.

Implication of Central β(2) Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease

Wang A, Since M, Dallemagne P, Rochais C.

Arch Pharm (Weinheim). 2025 Apr;358(4):e2400750. doi: 10.1002/ardp.202400750.

Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer's disease

Khandayataray P, Murthy MK.

Neuroscience. 2025 May 14;574:21-41. doi: 10.1016/j.neuroscience.2025.03.066. Epub 2025 Apr 4.

The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model

Titisari N, Ahmad H, Samsulrizal N, Fauzi A, Abdul Razak IS.

Open Vet J. 2025 Feb;15(2):594-600. doi: 10.5455/OVJ.2025.v15.i2.8. Epub 2025 Feb 28.

Exploring Retinal Neurodegeneration in Alzheimer's Disease: A Molecular and Cellular Perspective

Dhapola R, Sharma P, Kumari S, Vellingiri B, Medhi B, HariKrishnaReddy D.

Neurotox Res. 2025 Apr 12;43(2):22. doi: 10.1007/s12640-025-00744-4.

Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation

Liu Y, Aquili L, Wong KH, Lu Z, Lim LW.

Ageing Res Rev. 2025 Jun;108:102755. doi: 10.1016/j.arr.2025.102755. Epub 2025 Apr 14.

Impact of corticoid receptors on Alzheimer's disease: a neuroendocrine perspective

Goel F, Kumar D, Sharma A.

Inflammopharmacology. 2025 May;33(5):2641-2656. doi: 10.1007/s10787-025-01734-w. Epub 2025 Apr 18.

NLRP3 inflammasome in Alzheimer's disease: molecular mechanisms and emerging therapies

Li Z, Gong C.

Front Immunol. 2025 Apr 7;16:1583886. doi: 10.3389/fimmu.2025.1583886. eCollection 2025.

Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities

Belaidi AA, Bush AI, Ayton S.

Mol Neurodegener. 2025 Apr 24;20(1):47. doi: 10.1186/s13024-025-00843-y.

Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer's Disease, Creutzfeldt-Jakob Disease and Cerebral Amyloid Angiopathy

Karatzetzou S, Ioannidis S, Konstantinopoulou E, Parisis D, Afrantou T, Ioannidis P.

Biomolecules. 2025 Apr 3;15(4):522. doi: 10.3390/biom15040522.

Role of Ion Channels in Alzheimer's Disease Pathophysiology

Bhoi R, Mitra T, Tejaswi K, Manoj V, Ghatak S.

J Membr Biol. 2025 Jun;258(3):187-212. doi: 10.1007/s00232-025-00341-8. Epub 2025 May 1.

Small molecule-mediated therapeutic approaches to target Tau and Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;145:287-304. doi: 10.1016/bs.apcsb.2024.11.010. Epub 2024 Dec 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias